Caris Life Sciences has launched a new diagnostic tool that aims to help guide treatment decisions for people with…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMXT 1501 to treat…
Researchers have developed a new cell therapy that aims to treat endometrial cancer by targeting cancer cells while also depleting…
Add-on treatment with mezigdomide significantly delayed cancer progression among people with hard-to-treat myeloma in a Phase 3 clinical trial,…
Sellas Life Sciences is seeking people with newly diagnosed acute myeloid leukemia (AML) for a clinical trial testing…
People with advanced pancreatic cancer who followed a ketogenic diet program administered by Virta Health while receiving chemotherapy…
A combination of two immune-modulating treatments, Lymphir (denileukin diftitox) and Keytruda (pembrolizumab), was well tolerated in an exploratory clinical trial…
The U.S. Food and Drug Administration (FDA) has approved the combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab…
Treatment with the targeted therapy Venclexta (venetoclax) in combination with chemotherapy led to disease remission for most people with hard-to-treat…
The experimental therapy 177Lu-edotreotide outperformed the approved treatment everolimus in prolonging progression-free survival in people with pancreatic neuroendocrine tumors…